Schwabe R - Search Results

1

Immunology and immunotherapy of cholangiocarcinoma.

Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, Wang XW. Greten TF, et al. Among authors: schwabe r. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):349-365. doi: 10.1038/s41575-022-00741-4. Epub 2023 Jan 25. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36697706 Review.

2

The gut microbiome and liver cancer: mechanisms and clinical translation.

Yu LX, Schwabe RF. Yu LX, et al. Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):527-539. doi: 10.1038/nrgastro.2017.72. Epub 2017 Jul 5. Nat Rev Gastroenterol Hepatol. 2017. PMID: 28676707 Free PMC article. Review.

3

Gut microbiome in HCC - Mechanisms, diagnosis and therapy.

Schwabe RF, Greten TF. Schwabe RF, et al. J Hepatol. 2020 Feb;72(2):230-238. doi: 10.1016/j.jhep.2019.08.016. J Hepatol. 2020. PMID: 31954488 Review.

4

Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis.

Zhu C, Tabas I, Schwabe RF, Pajvani UB. Zhu C, et al. Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):131-142. doi: 10.1038/s41575-020-00365-6. Epub 2020 Oct 13. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33051603 Free PMC article. Review.

5

The microbiome and cancer.

Schwabe RF, Jobin C. Schwabe RF, et al. Nat Rev Cancer. 2013 Nov;13(11):800-12. doi: 10.1038/nrc3610. Epub 2013 Oct 17. Nat Rev Cancer. 2013. PMID: 24132111 Free PMC article. Review.

6

Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.

Mu X, Pradere JP, Affò S, Dapito DH, Friedman R, Lefkovitch JH, Schwabe RF. Mu X, et al. Among authors: schwabe rf. Gastroenterology. 2016 Mar;150(3):720-33. doi: 10.1053/j.gastro.2015.11.039. Epub 2015 Nov 26. Gastroenterology. 2016. PMID: 26627606 Free PMC article.

7

Apoptosis and necroptosis in the liver: a matter of life and death.

Schwabe RF, Luedde T. Schwabe RF, et al. Nat Rev Gastroenterol Hepatol. 2018 Dec;15(12):738-752. doi: 10.1038/s41575-018-0065-y. Nat Rev Gastroenterol Hepatol. 2018. PMID: 30250076 Free PMC article. Review.

8

Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation.

Song X, Xu H, Wang P, Wang J, Affo S, Wang H, Xu M, Liang B, Che L, Qiu W, Schwabe RF, Chang TT, Vogl M, Pes GM, Ribback S, Evert M, Chen X, Calvisi DF. Song X, et al. J Hepatol. 2021 Oct;75(4):888-899. doi: 10.1016/j.jhep.2021.05.018. Epub 2021 May 28. J Hepatol. 2021. PMID: 34052254 Free PMC article.

9

TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.

Wang X, Zeldin S, Shi H, Zhu C, Saito Y, Corey KE, Osganian SA, Remotti HE, Verna EC, Pajvani UB, Schwabe RF, Tabas I. Wang X, et al. J Hepatol. 2022 Apr;76(4):910-920. doi: 10.1016/j.jhep.2021.11.031. Epub 2021 Dec 11. J Hepatol. 2022. PMID: 34902531 Free PMC article.

10

β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.

Zhang Y, Xu H, Cui G, Liang B, Chen X, Ko S, Affo S, Song X, Liao Y, Feng J, Wang P, Wang H, Xu M, Wang J, Pes GM, Ribback S, Zeng Y, Singhi A, Schwabe RF, Monga SP, Evert M, Tang L, Calvisi DF, Chen X. Zhang Y, et al. Gastroenterology. 2022 Aug;163(2):481-494. doi: 10.1053/j.gastro.2022.04.028. Epub 2022 Apr 27. Gastroenterology. 2022. PMID: 35489428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page